N- (2 -hydroxyethyl) -N-methyl4- (quinolin8-yl (1- (thiazol-4ylmethyl) piperidin4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression.
Details for Australian Patent Application No. 2007313515 (hide)
International Classifications
Event Publications
7 May 2009 PCT application entered the National Phase
PCT publication WO2008/048171 Priority application(s): WO2008/048171
25 November 2010 Application Accepted
Published as AU-B-2007313515
24 March 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007313523-Cryptographic key management in communication networks
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser